Evidence map›Paper›PMID 33135871›Full record

Observational studyInternational forum of allergy & rhinology2021

Inflammation-driven vascular dysregulation in chronic rhinosinusitis.

Nitish Khurana, Abigail Pulsipher, Jolanta Jedrzkiewicz, Shaelene Ashby, Chelsea E Pollard, Hamidreza Ghandehari, Jeremiah A Alt

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in International forum of allergy & rhinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Decreased Production of Tissue Plasminogen Activator in Endothelial Cells From Nasal Polyps.World journal of otorhinolaryngology - head and neck surgery · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. [Research progress of type 2 inflammation-related tissue remodeling in nasal polyps].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Review
  8. Observational
  9. Article
  10. Article
  11. Systemic administration of budesonide in pegylated liposomes for improved efficacy in chronic rhinosinusitis.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nitish KhuranaDepartment of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT.
Abigail PulsipherUtah Center for Nanomedicine, Nano Institute of Utah, University of Utah, Salt Lake City, UT.
Jolanta JedrzkiewiczDepartment of Pathology, University of Utah, Salt Lake City, UT.
Shaelene AshbySinus and Skull Base Surgery Program, Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Utah, Salt Lake City, UT.
Chelsea E PollardUtah Center for Nanomedicine, Nano Institute of Utah, University of Utah, Salt Lake City, UT.
Hamidreza GhandehariDepartment of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT.
Jeremiah A AltDepartment of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT.ORCID 0000-0003-0560-5028
University of Utah · US

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
DETERMINANTS OF SURGICAL OUTCOMES IN CHRONIC SINUSITISR01DC005805 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI SMITH, TIMOTHY L, SOLER, ZACHARY M · 2004 to 2020
$7.6M
A Novel Glycosaminoglycan-Based Therapeutic for Chronic RhinosinusitisR44AI126987 · NIAID · GLYCOMIRA, LLC · PI SAVAGE, JUSTIN RODNEY · 2018 to 2022
$4.4M
A Novel Glycosaminoglycan-Based Therapeutic for Chronic RhinosinusitisR43AI126987 · NIAID · GLYCOMIRA, LLC · PI ALT, JEREMIAH ANDREW, PRESTWICH, GLENN DOWNES · 2016 to 2016
$298k
NCATS NIH HHS UL1 TR002538NIAID NIH HHS R43 AI126987NIAID NIH HHS R44 AI126987NIDCD NIH HHS R01 DC005805
6 · The paper itself

Abstract

backgroundAltered neovascularity is typically observed in chronic inflammatory diseases with overlapping pathophysiology to that observed in chronic rhinosinusitis (CRS). However, characterization of these inflammatory-induced vascular-mediated changes in CRS is limited. Understanding the underlying vascular changes in CRS will allow for strategic design and development of new drug-delivery technologies that exploit vascular permeability for increased extravasation into the target sinonasal tissues.

methodsPatients with CRS with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP) and non-CRS controls were enrolled in this prospective, observational study. The extent of angiogenesis in tissue was characterized using immunohistochemical and multiplex gene expression analyses. Vascular permeability, interendothelial junction structures, and endothelial barrier morphology were evaluated using transmission electron microscopy.

resultsSinonasal vascularity was increased significantly in CRSsNP and CRSwNP (p < 0.05) when compared with controls, as assessed by enumerating the platelet endothelial cell adhesion molecule (PECAM-1)-positive blood vessels. Pro-angiogenic gene expression, including PECAM1 and platelet-activating factor receptor, was elevated significantly in patients with CRSwNP when compared with controls (p < 0.05). The fenestration sizes between endothelial cells (17-280 nm) were larger in CRSwNP compared with CRSsNP (10-33 nm) patients and controls (4-12 nm). Global thinning of the endothelial cell lining was observed in CRS patients but not in controls.

conclusionSignificant increases in vascularity, the pro-angiogenic gene, and protein expression and blood vessel morphogenesis were observed in CRS patients compared with controls. In addition, fenestration sizes between interendothelial junction structures were larger in CRS patients than in controls, suggesting inflammation-driven vascular dysregulation in CRS pathology.

Indexed as

Nasal PolypsRhinitisSinusitisChronic DiseaseEndothelial CellsHumansInflammationProspective Studies

Identifiers

PMID33135871
PMCPMC8088451
OpenAlexW3097736198

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.